79 related articles for article (PubMed ID: 165884)
21. Leukemoid reaction induced by different transplantable tumors in three inbred mouse strains.
Castillo R; Díaz JW; Veloso A; Gavilondo J
Neoplasma; 1982; 29(1):73-9. PubMed ID: 7070557
[TBL] [Abstract][Full Text] [Related]
22. High uridine phosphorylase activity in human melanoma tumor.
Leyva A; Kraal I; Lankelma J; Delemarre JF; Pinedo HM
Anticancer Res; 1983; 3(4):227-31. PubMed ID: 6881921
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034
[TBL] [Abstract][Full Text] [Related]
24. Determinants in chemosensitivity of oncogene-transformed NIH3T3 cells to 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine.
Zhang M; Endo Y; Sasaki T
Int J Oncol; 1999 Mar; 14(3):543-9. PubMed ID: 10024689
[TBL] [Abstract][Full Text] [Related]
25. Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing mice.
Drake WP; Kopyta LP; Levy CC; Mardiney MR
Cancer Res; 1975 Feb; 35(2):322-4. PubMed ID: 1053698
[TBL] [Abstract][Full Text] [Related]
26. Uridine kinase: altered subunit size or enzyme expression as a function of cell type, growth stimulation, or mutagenesis.
Cheng N; Traut TW
J Cell Biochem; 1987 Nov; 35(3):217-29. PubMed ID: 2826505
[TBL] [Abstract][Full Text] [Related]
27. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
[TBL] [Abstract][Full Text] [Related]
28. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
29. Effects of N-(phosphonacetyl)-L-aspartate on murine tumors and normal tissues in vivo and in vitro and the relationship of sensitivity to rate of proliferation and level of aspartate transcarbamylase.
Johnson RK; Swyryd EA; Stark GR
Cancer Res; 1978 Feb; 38(2):371-8. PubMed ID: 620408
[No Abstract] [Full Text] [Related]
30. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo radiation sensitization by the halogenated pyrimidine 5-chloro-2'-deoxycytidine.
Russell KJ; Rice GC; Brown JM
Cancer Res; 1986 Jun; 46(6):2883-7. PubMed ID: 3698014
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.
Yamagami K; Fujii A; Arita M; Okumoto T; Sakata S; Matsuda A; Ueda T; Sasaki T
Cancer Res; 1991 May; 51(9):2319-23. PubMed ID: 2015596
[TBL] [Abstract][Full Text] [Related]
33. [Elastase activity during growth and metastasis of tumors andthe pharmacological effects in C57Bl/6 mice].
Chubinskaia SG
Eksp Onkol; 1990; 12(1):53-6. PubMed ID: 2298144
[TBL] [Abstract][Full Text] [Related]
34. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y
Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518
[TBL] [Abstract][Full Text] [Related]
35. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Sirotnak FM; Otter GM; Schmid FA
Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
[TBL] [Abstract][Full Text] [Related]
36. Structural comparison of deoxycytidine kinases purified from cells sensitive (P815) or resistant (P815/ara-C) to 1-beta-D-arabinofuranosylcytosine.
Meyers MB; Kreis W
Cancer Res; 1978 Apr; 38(4):1099-104. PubMed ID: 639039
[No Abstract] [Full Text] [Related]
37. Biological evaluation of mitoxantrone dihydrochloride synthesized by a new method. I. Acute toxicity and antitumor activity in mouse transplantable tumor systems.
Matuszyk J; Kuśnierczyk H; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):77-88. PubMed ID: 2619512
[TBL] [Abstract][Full Text] [Related]
38. [Pyridoxal kinase activity in human tumor tissues].
Draudin-Krylenko VA
Vopr Med Khim; 1977; 23(5):592-6. PubMed ID: 202094
[TBL] [Abstract][Full Text] [Related]
39. [Effect of treatments of different modalities on the nucleoside phosphate kinase activity of normal and neoplastic cells].
Tret'iakov AV; Riazanov EM; Filov VA
Biull Eksp Biol Med; 1985 Oct; 100(10):477-9. PubMed ID: 2996657
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of pyrimidine nucleotides in various tissues and tumor cells from rodents.
Ikenaka K; Fukushima M; Nakamura H; Okamoto M; Shirasaka T; Fujii S
Gan; 1981 Aug; 72(4):590-7. PubMed ID: 6273249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
